Future-Proofing Alzheimer’s Care – REAL AD Recognized as a European Best Practice Example
October 6, 2025
In recognition of World Alzheimer’s Month, we are proud to share the new report “Future Proofing the Alzheimer’s Disease Healthcare Journey”, developed in collaboration with the EFPIA – European Federation of Pharmaceutical Industries and Associations.
The report highlights how healthcare systems around the world need to evolve to meet the needs of people living with Alzheimer’s disease. As new diagnostic tools and therapies become available, innovative approaches are required to ensure early diagnosis, coordinated support, and equitable access to care.
The report presents scalable, real-world innovations from eight European countries, along with concrete recommendations for making future Alzheimer’s care more equitable, effective, and sustainable.
At REAL AD, we are proud to be one of the selected European best practice examples featured in the report. Our work in Sweden with blood-based biomarkers and digital cognitive screening is highlighted as an example of how new technologies can support earlier detection and more person-centered dementia care.
By learning from successful initiatives in countries such as France, Spain, and Sweden, healthcare systems around the world can prepare for the next generation of Alzheimer’s care – care that is future-ready, coordinated, and compassionate.
Read the full report here: Future Proofing the Alzheimer’s Disease Healthcare Journey